FGFR3 and Miyoshi myopathy: The t(4;14) translocation in MM, resulting in the fusion of the fibroblast growth factor receptor 3 gene with an IgH enhancer, leads to overexpression of fibroblast growth factor receptor 3 and subsequent activation of the RAS/MAPK pathway [89].